Skip to main content

Table 3 The activation markers on (unstimulated) peripheral neutrophils between COPD group 1 and COPD group 2

From: Proteomic profiling of peripheral blood neutrophils identifies two inflammatory phenotypes in stable COPD patients

Activation markers

COPD group 1

(N = 17)

COPD group 2

(N = 22)

Statistics

MFI

Mean ± SD

Mean ± SD

 

CD11b

85 ± 36

78 ± 64

0.699

CD18

96 ± 67

80 ± 31

0.371

CD64

38 ± 65

27 ± 31

0.493

CD66b

75 ± 36

78 ± 34

0.762

Active FcγRII

65 ± 68

120 ± 239

0.367

CD32

214 ± 52

233 ± 34

0.136

CXCR1

190 ± 58

188 ± 49

0.936

CD62L

255 ± 234

194 ± 75

0.317

CD45

10 ± 4.86

11 ± 4.12

0.541

CXCR2

64 ± 17

67 ± 30

0.920

CD35

31 ± 15

32 ± 21

0.310

CD15

958 ± 363

1171 ± 519

0.920

CD63

4.02 ± 0.78

4.46 ± 1.42

0.920

CD44

541 ± 114

579 ± 163

0.152

N29

17 ± 4

19 ± 11

0.920

  1. MFI median fluorescence intensity, SD standard deviation